These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6242778)

  • 1. Need stable diabetics mix their insulins?
    Roland JM
    Diabet Med; 1984 May; 1(1):51-3. PubMed ID: 6242778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens.
    Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW
    Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily insulin regimens in management of severe diabetes.
    Oakley N; Mather H; Hadley L; Lynch J; Pilkington T
    J R Soc Med; 1981 May; 74(5):363-7. PubMed ID: 7017138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of premixed with patient-mixed insulins.
    Corcoran JS; Yudkin JS
    Diabet Med; 1986 May; 3(3):246-9. PubMed ID: 2951178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two twice-daily insulin regimens: ultralente/soluble and soluble/isophane.
    Ward GM; Simpson RW; Ward EA; Turner RC
    Diabetologia; 1981 Oct; 21(4):383-6. PubMed ID: 7026334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects.
    Pramming S; Lauritzen T; Thorsteinsson B; Johansen K; Binder C
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):215-20. PubMed ID: 6364670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for the most practical regular/NPH mixtures for type I diabetic patients.
    Renner R; Vocke K; Hepp KD
    Diabetes Care; 1982; 5 Suppl 2():53-6. PubMed ID: 6765541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human isophane or lente insulin? A double blind crossover trial in insulin dependent diabetes mellitus.
    Gibb DM; Foot AB; May B; Parish H; Strang S; Grant DB; Dunger DB
    Arch Dis Child; 1990 Dec; 65(12):1334-7. PubMed ID: 2270941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of intermediate-acting insulin preparations to daytime insulin treatment.
    Robert JJ; Chevenne D; Debray M
    Diabet Med; 1989 Aug; 6(6):531-6. PubMed ID: 2527136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diabetic control in adolescents using the Penject syringe for multiple insulin injections.
    McCaughey ES; Betts PR; Rowe DJ
    Diabet Med; 1986 May; 3(3):234-6. PubMed ID: 2951175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of biosynthetic human insulin with porcine insulin in the blood glucose control of diabetic pregnancy.
    Leiper JM; Paterson KR; Lunan CB; MacCuish AC
    Diabet Med; 1986 Jan; 3(1):49-51. PubMed ID: 2951136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
    Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
    J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes.
    Best JD; Ley CJ; Strauss BJ; Alford FP; Aitken PM
    Med J Aust; 1987 Jun; 146(12):621-3, 627. PubMed ID: 3306298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.